Form 4: Protagonist Therapeutics CEO Gifts Shares
Insider Transaction Report
Protagonist Therapeutics CEO Dinesh Patel reports gifting 620 common shares.
Summary
- Dinesh V. Patel, President and CEO of Protagonist Therapeutics, Inc. (PTGX), reported a change in beneficial ownership.
- On September 16, 2025, Mr. Patel disposed of 620 shares of Protagonist Therapeutics Common Stock.
- The transaction was a bona fide gift of securities to his son, with a reported price of $0 per share.
- Following this transaction, Mr. Patel directly beneficially owns 519,983 shares of common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine insider gift of shares, which is a neutral event for company operations and financial health, reflecting personal financial management rather than corporate performance.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- "This transaction involves a bona fide gift of securities from the Reporting Person to his son."
Industry Context
This filing reports a routine insider transaction, specifically a gift of shares by a senior executive, which is a common personal financial management activity and does not typically reflect broader industry trends or company operational performance.
Related Party Transactions
- Dinesh V. Patel, President and CEO, gifted 620 shares of common stock to his son.
Stakeholder Impact
- Shareholders: Minimal direct impact as the transaction is a small, non-market gift by an insider and does not affect the company's fundamentals.
- Employees, Customers, Suppliers, Creditors: No discernible impact from this personal transaction.
Key Dates
| Date | Description |
|---|---|
| 09/16/2025 | Date of transaction: bona fide gift of 620 common shares. |
| 09/18/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Recommendation
holdThe filing details a routine insider gift of shares by the CEO, which does not reflect on the company's operational performance or future prospects. It is a personal financial management event for the executive and typically has no material impact on the stock's investment thesis, thus warranting a 'hold' recommendation based solely on this filing.
Keywords
Protagonist Therapeutics, PTGX, Dinesh Patel, Insider Transaction, Stock Gift, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.